Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Information for Contributors
Health Security is a bimonthly peer-reviewed journal. Its purpose is to serve as an international forum for debate and exploration of the key strategic, scientific, and operational issues posed by biological weapons and bioterrorism. The Journal provides multidisciplinary analyses and perspectives essential to the creation of strategies and programs that can diminish the threat of bioweapons.
The intended audiences for this Journal are those professional communities that have strategic, scientific, or operational responsibilities critical to improving biosecurity, including medicine, public health, law, national security, bioscientific research, agriculture, food safety, and drug and vaccine development.
The Editors encourage submissions to the Journal from professionals in these fields and others who have the responsibility or opportunity to improve biosecurity. Contributors are asked to follow these guidelines:
• Send an outline or letter to Jaclyn Fox at firstname.lastname@example.org summarizing your paper before submitting—or even writing—the paper. We can give you quick feedback on whether the idea fits the journal.
• Do not submit papers that have been published or that are currently being considered by another journal.
• Original articles, reports, and case studies should range from 3,000 to 5,000 words. Leading edge review papers of a scientific concept or technological application of relevance to biodefense or bioweapons development may be up to 5,000 words in length.
• Editorials and commentaries may be on any issues of relevance to the field but should be succinct and include appropriate documentation. Letters to the Editors intended for publication should be no more than 500 words and may be edited.
• Avoid jargon and overly technical presentations. Our readers come from a number of different fields, and your article should be understandable to well-informed, intelligent readers from various disciplines.
• In addition to presenting the methods and results of a study, you should draw implications from the results and discuss their relevance.
• All authors and co-authors, by definition, are responsible for a significant part of the manuscript. All authors should have taken part in writing the paper, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a paper assumes responsibility and accountability for the content. All authors will be required to sign a copyright release form.
CONFLICT OF INTEREST
Authors must disclose any potential conflict of interest, financial or otherwise, when submitting a manuscript. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.
Manuscripts must be submitted online using the following url:
• Submit all manuscripts double blinded and do not put your name on every page.
• All material published in the journal is copyrighted by Mary Ann Liebert, Inc., including print and electronic rights. This ensures that requests from third parties to reproduce papers are handled efficiently and consistently and will also allow the material to be as widely disseminated as possible. Forms for this purpose will be sent to authors when manuscripts have been accepted for publication. Authors may use their own material in other publications, provided that the Journal is acknowledged as the original place of publication and that the publisher is notified in advance.
CONSIDERATION OF INFORMATION THAT MIGHT INCREASE THE RISKS ASSOCIATED WITH POTENTIAL BIOWEAPON ATTACKS
Health Security was created to foster discussion of biosecurity and bioterrorism issues and to promote informed biodefense decision making amongst policymakers, technical experts, and the public. However, the editors recognize that, in the process of promoting this critical debate, some of the articles published in this journal may contain information, such as public health biodefense preparedness vulnerabilities, biotechnologies, experimental methodologies, and medical response capacities, that could arguably lower the barriers to bioweapons attacks and/or increase the potential consequences of those attacks. There exists a recognized and important tension between academic freedom and the potential for misapplication of scientific and other knowledge. Judgments must be made regarding the balancing of risks against the importance of an open, robust debate on these topics.
Given that essentially all biological science information is currently unclassified and available on the worldwide web and that medical and public health planning efforts are largely proceeding in the public domain, the editors believe that it will be a rare occasion that a decision not to publish potentially sensitive information will occur. While editorial procedures are in place to ensure such actions can occur should they be necessary, the editors have a strong commitment against withholding scientific or other information unless there are clear and compelling reasons to do so.
Preparation of Manuscripts
• Type the entire manuscript, including tables and figure legends, double-spaced with 1-inch margins on all sides. Number pages consecutively.
• Title page. The title page should have a title of about 45 characters (including spaces). Do not include authors’ names on this page or subsequent pages.
• Abstract. The abstract should state the topic of the article and provide a summary of its main points. It should not exceed 250 words.
• Text. Insert appropriate subheads in the text. A typical research article will have an introduction, material and methods, results, discussion, acknowledgments, and references. Policy articles, commentaries, and other types of articles should include appropriate subheads.
• Acknowledgments. Authors should acknowledge only those people and institutions that have made substantive contributions to the study. Details of sources of funding must be given, and any potential conflicts of interest must be declared (e.g., financial, personal, political, or academic).
• References. The references should be cited in the text using the numerical order of citation method. The reference list should be at the end of the paper, double-spaced, and organized numerically by order of citation. References should be presented according to the style of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Vancouver style) [http://www.icmje.org/], as shown below:
Chadee DD, Kitron U. Spatial and temporal patterns of imported malaria cases and local transmission in Trinidad. Am J Trop Med Hyg 1999;61:513-7.
Fish D. Population ecology of Ixodes dammin. In: Ginsberg H, ed. Ecology and Environmental Management of Lyme Disease. Rutgers, NJ: Rutgers University Press;1993:25-42.
• Tables. Submit each table as a separate file. Use Arabic numerals to number tables. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes.
• Illustrations. Cite figures consecutively within the manuscript.
Please follow these guidelines for submitting artwork:
• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at 1200 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed.
You will be given directions on how to correct any files which do not pass.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
• All files should be scanned at 100% size.
• 300 dpi
• Final color mode: cmyk
• save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go to https://home.liebertpub.com/MEDIA/pdf/ppconvert.pdf
• Permissions. Figures, tables, and text taken from other sources must be accompanied by a written statement from both author and publisher of the original material granting permission for reproduction. Include permission from authors to cite unpublished data or papers still in press.
• Reprints. Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215; Telephone: (914) 740–2100; fax: (914) 740–2108; e-mail: email@example.com; web site: www.liebertpub.com.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.